Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 83Pancreatic Neoplasms 26Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 10Biliary Tract Neoplasms 10Colorectal Neoplasms 9Neoplasm Metastasis 7Nasopharyngeal Carcinoma 5Cholangiocarcinoma 5Colonic Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Recurrence 3Head and Neck Neoplasms 3Advanced Pancreatic Cancer 3Rectal Neoplasms 2NSCLC 2Locally Advanced Pancreatic Cancer 2Locally Advanced Gastric Cancer 2Gastrointestinal Neoplasms 2Gastric Cancer Peritoneal Metastases 2Advanced Non-Small Cell Lung Cancer 2Advanced Gastric Cancer 2Adenocarcinoma 2mCRC 1Surgically-Created Resection Cavity 1Stage IV Gastric Cancer With Metastasis 1Squamous Cell Carcinoma of Head and Neck 1Progression Free Survival 1Preventive Effect of Quintuple Therapy on Metachronous Liver Metastases in Patients With Colorectal Cancer 1Pancreatic cancer, adult 1

Interventions

Oxaliplatin 2130-nm albumin-bound paclitaxel 2irinotecan sucrosofate 1folfirinox 1camrelizumab 1Surgical Procedures, Operative 1S 1 (combination) 1Leucovorin 1Gemcitabine 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Borderline Resectable Pancreatic Cancer × S 1 (combination) × Clear all
NCT03850769 2020-03-10

Neoadjuvant Nab-Paclitaxel and S-1 in Borderline Resectable Pancreatic Cancer

Peking Union Medical College Hospital

Phase 2 Unknown
60 enrolled
Gastrointestinal

Borderline Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡